A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation

British Journal of Cancer

Volumn 80, Issue 1-2, 1999, Pages 17-24

  Fajardo, I ^a   Quesada, A R ^a   Nunez De Castro I ^a   Sanchez Jimenez F ^a   Medina, M A ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Angiogenesis; Matrix metalloproteinase; Plasminogen activator inhibitor; Tissue inhibitor of matrix metalloproteinase; Urokinase

Indexed keywords

2 METHOXYESTRADIOL; ANGIOGENESIS INHIBITOR; ESTROGEN; GENISTEIN; ISOFLAVONE; MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR INHIBITOR; UROKINASE;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; DRUG CYTOTOXICITY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NEUROBLASTOMA CELL; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CELL DIVISION; COLLAGENASES; CULTURE MEDIA, CONDITIONED; ENDOPEPTIDASES; ESTRADIOL; EXTRACELLULAR MATRIX PROTEINS; GELATINASES; GENISTEIN; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; PEPTIDE HYDROLASES; PLASMINOGEN INACTIVATORS; PROTEASE INHIBITORS; PROTEIN-TYROSINE KINASES; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032921582     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690315     Document Type: Article

References (36)

1. Akiyama T, Ishida I, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M and Fuami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592-5595
2. Alvarez O, Carmichael DF and Declerk YA (1990) Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 82: 589-595
3. Andreasen PA, Georg B, Lund LR, Riccio A and Stacey SN (1990) Plasminogen activators inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 68: 1-19
4. Barnes S, Peterson G, Grubbs C and Setchell K (1994) Potential role of dietary isoflavones in the prevention of cancer. In Diet and Cancer: Markers, Prevention, and Treatment, Jacubs MM (ed) pp. 135-147. Plenum Press: New York
5. Blasi F, Riccio A and Sebatio G (1986) Human plasminogen activators: genes and protein structure. In Human Genes and Diseases, Blasi F (ed). pp. 377-414. Wiley: London
6. D'Amato RJ, Lin CM, Flynn E, Folkman J and Hamel E (1994) 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91: 3964-3968
7. Dano K, Andreasen PA, Grohndahl-Hansen J, Kristensen P, Nielsen LS and Skriver L (1985) Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44: 139-266
8. αd2 coincident with taxol-induced apoptosis. Cell Growth Differ 5: 1041-1050
9. Dunn JE (1975) Cancer epidemiology in populations of the United States - with emphasis on Hawaii and California - and Japan. Cancer Res 35: 3240-3245
10. Edmonard H and Grimaud JA (1990) Matrix metalloproteinases. A review. Cell Mol Biol 36: 131-153
11. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31
12. Folkman J and Shing Y (1992) Angiogenesis. J Biol Chem 267: 10931-10934
13. Fotsis T, Pepper M, Adlercreutz H, Fleischman G, Hase T, Montesano R and Schweigerer L (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90: 2690-2694
14. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nauroth PP and Schweigerer L (1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368: 237-239
15. García de Veas R, Schweigerer L and Medina MA (1995) Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumor cells. Effects of tumor cell proliferation modulators on gelatinolytic activity. J Cancer Res Clin Oncol 121: 275-278
16. Gohji K, Fujimoto N, Fujii A, Komiyama T, Okawa J and Nakajima M (1996) Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection. Cancer Res 56: 3196-3198
17. Gorczyca W, Gong J, Ardelt B, Traganos F and Darzynkiewicz Z (1993) The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 53: 3186-3192
18. Holmgren L, O'Reilly MS and Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1: 149-153
19. Kohn EC and Liotta LA (1995) Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55: 1856-1862
20. Lau HKF, Kim M, Koo J, Chiu B and Murray D (1995) Increase of a urokinase receptor-related low-molecular-weight molecule in colorectal adenocarcinomas. Clin Exp Metastasis 13: 492-498
21. Liotta LA, Tryggvason K, Garbisa S, Hart IR, Foltz CM and Shaflie S (1980) Metastatic potential correlates with enzymatic degradation of basement matrix collagen. Nature 284: 67-69
22. Liotta L, Rao CN and Bardsky SH (1983) Tumor invasion and the extracellular matrix. Lab Invest 49: 639-649
23. Liotta LA, Steeg PS and Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336
24. Messina MJ, Persky V, Setchell KDR and Barnes S (1994) Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21: 113-131
25. Montesano R (1992) Regulation of angiogenesis in vitro. Eur J Clin Invest 22: 504-515
26. Mossmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Method 65: 55-63
27. Nuovu GJ, MacConnell PB, Simsir A, Valea F and French DL (1995) Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 55: 267-275
28. Packman KS, Demeure MD, Doffek KM and Wilson SD (1995) Increased plasminogen activator and type IV collagenase activity in invasive follicular thyroid carcinoma cells. Surgery 118: 1011-1017
29. Parker SL, Tong T, Bolden S and Wingo PA (1996) Cancer statistics. CA Cancer J Clin 65: 5-27
30. Peterson G and Barnes S (1991) Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem. Biophys Res Commun 179: 661-667
31. Peterson G and Barnes S (1996) Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ 7: 1345-1351
32. Schweigerer L, Breit S, Wenzel A, Tsunamoto K, Ludwig R and Schwab M (1990) Augmented N-MYC expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activity. Cancer Res 50: 4411-4416
33. Schweigerer L, Christeleit K, Fleischmann G, Adlercreutz H, Wahala K, Hase T, Schwab M, Ludwig R and Fotsis T (1992) Identification in human urine of a natural growth inhibitor for cells derived from solid paediatric tumors. Eur J Clin Invest 22: 260-264
34. Severson RK, Nomura AMY, Grove J-S and Stemmerman GN (1989) A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49: 1857-1860
35. Stearns ME and Wang M (1993) Type IV collagenase (MW 72,000) expression in human prostate: benign and malignant tissue. Cancer Res 53: 878-883
36. Tsuchiya Y, Sato H, Endo Y, Okada Y, Mai M, Takuma S and Seiki M (1993) Tissue inhibitor of metalloproteinase I is a negative regulator of the metastatic ability of a human gastric cancer cell line, kkls, in the chick embryo. Cancer Res 53: 1397-1402